Amine compounds, their production and use
AssigneeTakeda Pharmaceutical Company Limited
InventorsKaneyoshi Kato, Jun Terauchi, Hiroaki Fukumoto, Mitsuru Kakihana
Life of this patent
Estimating the term…
Loading patent…
AssigneeTakeda Pharmaceutical Company Limited
InventorsKaneyoshi Kato, Jun Terauchi, Hiroaki Fukumoto, Mitsuru Kakihana
Estimating the term…
A compound of the formula: wherein Ar is an aromatic ring assembly group which may be substituted or a fused aromatic group which may be substituted; X is (i) a bond, (ii) —S—, —SO— or —SO2—, (iii) C1-6 alkylene, C2-6 alkenylene or C2-6 alkynylene, etc., (iv) —CO—O— or (v) —(CH2)p-X1—, —(CH2)p-X1—CH2)q-, —(CH2)r-CO—X1—, —SO2—NR8— or —(CH2)r-SO2—NR8— wherein X1 is O or NR8, R8 is H, a hydrocarbon group which may be substituted or an acyl, p is 0 to 5, q is 1 to 5, p+q is 1 to 5, and r is 1 to 4; Y is a divalent C1-6 aliphatic hydrocarbon group optionally containing O or S, which may be substituted; R1 and R2 each is H or a lower alkyl which may be substituted, or R1 and R2 form a N-containing heterocyclic ring which may be substituted; Ring A is a benzene ring which may be further substituted; and Ring B is a 4- to 8-membered ring which may be further substituted, or a salt thereof has the effect of inhibiting amyloid-β protein production and/or secretion and is useful as a pharmaceutical composition for preventing and/or treating the neurodegenerative disease, etc.
A compound of the formula:
An inhibitor for production and/or secretion of amyloid-β protein, which comprises a compound of the formula:
A method for making a pharmaceutical formulation for inhibiting production and/or secretion of amyloid-β protein comprising combining a compound of the formula:
Dependencies are inferred from the claim text.